Testosterone in Obese Men Trial

A 12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy and Lifestyle Modification Versus Lifestyle Modification Alone on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Middle-Aged and Older Men

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000283673

Enrollment

Registered

2005-09-02

Start date

2005-12-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy (Intramuscular Testosterone Undecanoate) and Lifestyle Modification.

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

Male

Age

40 Years to 70 Years

Healthy volunteers

Inclusion criteria

BMI between 30-39.9 kg/m2 and WC equal to or greater than102cm, Serum total Testosterone <12nM.

Exclusion criteria

Smokers, Significant medical condition, Sleep Apnoea, Contra-indications to Testosterone therapy.

Outcome results